FdaApplication
ANDA 206329
Identifiers
- fda_app_no: ANDA206329
Properties
| Property | Value |
|---|---|
| applicant_name | DR REDDYS LABORATORIES SA |
| application_type | ANDA |
| approval_date | 2022-08-22 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.3MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.6MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.1MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.2MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.4MG BASE | TABLET;BUCCAL, SUBLINGUAL |
| FENTANYL CITRATE | FENTANYL CITRATE | EQ 0.8MG BASE | TABLET;BUCCAL, SUBLINGUAL |
6 products